Form 4 for RMD ResMed|
Accepted 2025-05-22 00:00:00 ET · period of report 2025-05-20 · accession 0001127602-25-015264 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-22 | 2025-05-20 | RMD | De Witte Jan | Dir | S - Sale | $243.47 | -2,000 | 5,806 | -26% | -$486.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ReMed Common Stock | 2025-05-20 | S | D | 2,000 | $243.47 | 5,806 | D | — | — |